AR219150A1 - Procedimiento para preparar nuevos derivados de aminoazucares - Google Patents

Procedimiento para preparar nuevos derivados de aminoazucares

Info

Publication number
AR219150A1
AR219150A1 AR275445A AR27544579A AR219150A1 AR 219150 A1 AR219150 A1 AR 219150A1 AR 275445 A AR275445 A AR 275445A AR 27544579 A AR27544579 A AR 27544579A AR 219150 A1 AR219150 A1 AR 219150A1
Authority
AR
Argentina
Prior art keywords
aminoazucar
derivatives
procedure
preparing new
preparing
Prior art date
Application number
AR275445A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR219150A1 publication Critical patent/AR219150A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AR275445A 1978-02-14 1979-02-08 Procedimiento para preparar nuevos derivados de aminoazucares AR219150A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (1)

Publication Number Publication Date
AR219150A1 true AR219150A1 (es) 1980-07-31

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
AR275445A AR219150A1 (es) 1978-02-14 1979-02-08 Procedimiento para preparar nuevos derivados de aminoazucares

Country Status (26)

Country Link
US (1) US4273765A (OSRAM)
EP (1) EP0003616B1 (OSRAM)
JP (1) JPS54163511A (OSRAM)
AR (1) AR219150A1 (OSRAM)
AT (1) AT367451B (OSRAM)
AU (1) AU527318B2 (OSRAM)
CA (1) CA1121290A (OSRAM)
DE (2) DE2962165D1 (OSRAM)
DK (1) DK149599C (OSRAM)
ES (1) ES477653A1 (OSRAM)
FI (1) FI63062C (OSRAM)
FR (1) FR2416901A1 (OSRAM)
GR (1) GR72817B (OSRAM)
HU (1) HU181442B (OSRAM)
IE (1) IE47916B1 (OSRAM)
IL (1) IL56626A0 (OSRAM)
LU (1) LU80906A1 (OSRAM)
MC (1) MC1253A1 (OSRAM)
NL (1) NL7901182A (OSRAM)
NO (1) NO153011C (OSRAM)
NZ (1) NZ189625A (OSRAM)
PH (1) PH15084A (OSRAM)
PT (1) PT69218A (OSRAM)
SE (1) SE7901276L (OSRAM)
YU (1) YU41437B (OSRAM)
ZA (1) ZA79528B (OSRAM)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3166093D1 (en) * 1981-01-05 1984-10-18 Takeda Chemical Industries Ltd N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
JPH06503418A (ja) * 1990-11-30 1994-04-14 モノクロネティックス インターナショナル、インコーポレーテッド 慢性下位脊椎痛および頚部痛の診断法
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
EP1157696B1 (en) * 2000-05-24 2006-10-25 Pfizer Limited Treatment of rumen acidosis with alpha-amylase inhibitors
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
KR20070084455A (ko) * 2004-11-23 2007-08-24 워너-램버트 캄파니 엘엘씨 지질혈증 치료용 hmg co-a 환원효소 억제제로서의7-(2h-피라졸-3-일)-3,5-디히드록시-헵탄산 유도체
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
RU2010145944A (ru) * 2008-04-11 2012-05-20 Астеллас Фарма Инк. (Jp) Аминосахарное соединение и способ его получения
CA2930674A1 (en) 2008-06-04 2009-12-10 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010093601A1 (en) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Novel sulfonic acid-containing thyromimetics, and methods for their use
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク 2−フェニルベンゾイルアミド
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012120414A2 (en) 2011-03-04 2012-09-13 Pfizer Inc. Edn3-like peptides and uses thereof
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR101695582B1 (ko) 2013-04-17 2017-01-13 화이자 인코포레이티드 심혈관 질환을 치료하기 위한 n-피페리딘-3-일벤즈아미드 유도체
SI3004138T1 (sl) 2013-06-05 2024-07-31 Bausch Health Ireland Limited Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
JP6769963B2 (ja) 2014-08-29 2020-10-14 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ α−アミノ−β−カルボキシムコン酸セミアルデヒド脱炭酸酵素の阻害剤
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP2020500838A (ja) 2016-10-14 2020-01-16 ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ Α−アミノ−β−カルボキシムコン酸セミアルデヒドデカルボキシラーゼの阻害剤
MX2021005904A (es) 2018-11-20 2021-09-08 Tes Pharma S R L Inhibidores de la ácido alfa-amino-beta-carboximucónico semialdehído descarboxilasa.
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
PT69218A (en) 1979-03-01
AU4402879A (en) 1979-08-23
FI790486A7 (fi) 1979-08-15
IE790274L (en) 1979-08-14
HU181442B (en) 1983-07-28
LU80906A1 (de) 1980-09-24
AT367451B (de) 1982-07-12
DK61179A (da) 1979-08-15
ES477653A1 (es) 1980-03-01
FR2416901A1 (fr) 1979-09-07
DE2905649A1 (de) 1979-08-16
YU41437B (en) 1987-06-30
JPS54163511A (en) 1979-12-26
PH15084A (en) 1982-07-02
US4273765A (en) 1981-06-16
ATA108879A (de) 1981-11-15
NZ189625A (en) 1981-05-01
SE7901276L (sv) 1979-08-15
FR2416901B1 (OSRAM) 1980-10-24
NL7901182A (nl) 1979-08-16
DE2962165D1 (en) 1982-03-25
ZA79528B (en) 1980-02-27
AU527318B2 (en) 1983-02-24
NO153011B (no) 1985-09-23
NO153011C (no) 1986-01-02
DK149599C (da) 1987-06-01
EP0003616B1 (de) 1982-02-24
CA1121290A (en) 1982-04-06
MC1253A1 (fr) 1980-01-14
FI63062C (fi) 1983-04-11
FI63062B (fi) 1982-12-31
JPS643877B2 (OSRAM) 1989-01-23
DK149599B (da) 1986-08-04
EP0003616A3 (en) 1979-09-05
GR72817B (OSRAM) 1983-12-06
IL56626A0 (en) 1979-05-31
IE47916B1 (en) 1984-07-25
YU34879A (en) 1983-01-21
EP0003616A2 (de) 1979-08-22
NO790469L (no) 1979-08-15

Similar Documents

Publication Publication Date Title
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
ES497884A0 (es) Procedimiento para preparar derivados de 2-amino-4-hidroxi- quinazolina
AR225143A1 (es) Procedimiento para preparar derivados de fenil-metil-hidantoina
MX5973E (es) Procedimiento para preparar compuestos cefem
MX5880E (es) Procedimiento para preparar derivados de bencilimidazol
ES490504A0 (es) Procedimiento para preparar nuevos compuestos de tiadiazoli-lo
ES488593A0 (es) Procedimiento para preparar derivados de ciclopropano
ES488635A0 (es) Procedimiento para preparar derivados de pirimidina
ES494119A0 (es) Procedimiento para preparar derivados de 3-aminoproxiarilo
MX5399E (es) Procedimiento para preparar derivados de propanona
ES492032A0 (es) Procedimiento para preparar compuestos de cefem
ES488772A0 (es) Procedimiento para preparar derivados de pirimidona
AR226694A1 (es) Procedimiento para obtener nuevos derivados de antraciclina
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
MX151851A (es) Procedimiento mejorado para preparar derivados de triacina
MX6291E (es) Procedimiento para preparar derivados de n-bencilhalogenoacetamida
AR228020A1 (es) Procedimiento para preparar derivados de 2-benciliden-benzofuran-3-ona
MX5724E (es) Procedimiento para preparar metil eteres de cetoximas sustituidas
MX6971E (es) Procedimiento para preparar derivados de tetrahidroquinolina
MX5160E (es) Procedimiento mejorado para preparar derivados de aminoalcoholes
ES492394A0 (es) Procedimiento para preparar derivados de pirimidina
AR223161A1 (es) Procedimiento para preparar n-etiletilendiamina
ES492692A0 (es) Procedimiento para preparar derivados de benoimidazol
AR223177A1 (es) Procedimiento para preparar derivados de indolo-isoquinolina
MX150040A (es) Procedimiento mejorado para preparar 3-metil-ciclopentadecanona